Active substance

Results for the substance odevixibat

8 results

About this active substance

Odevixibat is an ileal bile acid transporter inhibitor used for the treatment of progressive familial intrahepatic cholestasis (PFIC). It works by reducing the reabsorption of bile acids in the intestine, thereby decreasing their accumulation in the liver and alleviating disease symptoms.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor the response to treatment.

Patients should be aware of potential side effects, such as diarrhea, abdominal pain, or fatigue. It is important to inform the doctor of any unusual symptoms.

Common side effects include diarrhea, abdominal pain, fatigue, and decreased appetite. In rare cases, severe reactions such as elevated liver enzymes or allergic reactions may occur. Patients should be informed of these risks before starting treatment.